Skip to main content

Summer COVID Cases Are Rising Across America

Medically reviewed by Carmen Pope, BPharm. Last updated on June 25, 2024.

By Robin Foster HealthDay Reporter

TUESDAY, June 25, 2024 -- As scorching summer temperatures drive Americans indoors and millions travel for vacations and family gatherings, COVID infections are again climbing, U.S. health officials warned Monday.

In evidence that suggests a COVID summer wave is underway, case counts are most likely increasing in 39 states and aren’t declining anywhere in the country, new data from the U.S. Centers for Disease Control and Prevention shows.

While the CDC no longer tracks COVID cases, it still estimates spread of the virus using data on emergency department visits. Both COVID deaths and ED visits have risen in the last week, while hospitalizations climbed 25% from May 26 to June 1, according to the latest CDC data.

“It looks like the summer wave is starting to begin,” Dr. Thomas Russo, chief of infectious diseases at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences, told NBC News.

Several new COVID variants are likely contributing to the summer spike in cases, Dr. Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center in Boston, told NBC News.

“We’re seeing the start of an uptick of infections that is coincident with new variants that are developing: KP.2 and KP.3 and LB.1. It does appear that those variants do have an advantage over the prior ones,” he added.

All three variants are descendants of JN.1, the version of the coronavirus that dominated this winter.

KP.2 became the dominant variant last month, and then KP.3 took over in early June, NBC News reported. Along with a third variant that shares the same key mutations, KP.1.1, the group now accounts for around 63% of all COVID infections in the United States, CDC data shows.

Meanwhile, LB.1 accounts for another 17.5% of COVID infections. Experts said its rapid growth indicates that it’s likely to become dominant soon.

Still, “it’s sort of the newest kid on the block,” Barouch said. “There’s not much known about it.”

A preprint study released this month, which hasn’t yet been peer-reviewed, suggests LB.1 is more infectious and could be better at evading protection from vaccines or previous infections.

“Assuming that preliminary data is true, that it’s more immune-evasive and that it’s more infectious than KP.2 and KP.3, that’s a winning formula to infect more people,” Russo noted.

Apart from variants, experts said cases will probably continue to rise as people retreat indoors to escape the heat and gather to celebrate the Fourth of July.

Russo recommended that people who are vulnerable to infection and severe illness, or who are more likely to attend large parties or gatherings, consider getting the latest COVID vaccine.

He added that a monoclonal antibody drug called Pemgarda has been available since April for immunocompromised people. The antiviral medication Paxlovid can also lower the likelihood of hospitalization or death.

As for young, healthy people, they can hold out for the updated COVID vaccines expected to arrive this fall, experts said.

This month, the U.S. Food and Drug Administration advised vaccine manufacturers to target the KP.2 variant. The CDC’s Advisory Committee on Immunization Practices is set to meet Thursday to decide who should get those shots.

Sources

  • U.S. Centers for Disease Control and Prevention, data, June 24, 2024
  • NBC News

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted June 2024

Further Support and Information on COVID-19

Read this next

Long-Lasting HIV Prevention Shot Headed Toward Approval

FRIDAY, June 6, 2025 — A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month. If approved, the shot...

Moderna's New Lower-Dose COVID-19 Vaccine, mNexspike, Approved by FDA

TUESDAY, June 3, 2025 -- The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory...

CDC Now Says Americans Traveling Abroad Should Get Measles Shots First

TUESDAY, June 3, 2025 — Americans planning to travel outside the country should make sure they’re vaccinated against measles — no matter where they’re...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.